The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population

Categoria dell'articolo: Original Article

Pubblicato online: 09 lug 2016

Pagine: 33 - 36

DOI: https://doi.org/10.1515/bjmg-2015-0083

Parole chiave

Cancer, Checkpoint kinase 2 () gene, Chernobyl disaster liquidators, del5395

© 2016 Walter de Gruyter GmbH, Berlin/Boston

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.